Tech Company Financing Transactions
Gen9 Funding Round
Threshold Ventures participated in a $500 thousand funding round for Gen9. The financing round was announced on 12/31/2011.
Transaction Overview
Company Name
Announced On
12/31/2011
Transaction Type
Venture Equity
Amount
$500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
840 Memorial Dr. 5th Floor
Cambridge, MA 01239
USA
Cambridge, MA 01239
USA
Phone
Website
Email Address
Overview
Don t waste time picking colonies. Gen9 s innovative process provides sequence-perfect, clonal gene synthesis products at the best price in the industry.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kevin Munnelly
Chief Financial Officer
David Stone
VP - Bus. Development
Aaron Zucker
VP - Marketing
Leda Notchey
VP - R & D
Devin Leake
Browse more venture capital transactions:
Prev: 12/31/2011: Vital Access venture capital transaction
Next: 12/31/2011: Flexuspine venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs